WO2014069649A1 - Processes for production of intermediates for 2-alkyl cephem compounds - Google Patents
Processes for production of intermediates for 2-alkyl cephem compounds Download PDFInfo
- Publication number
- WO2014069649A1 WO2014069649A1 PCT/JP2013/079803 JP2013079803W WO2014069649A1 WO 2014069649 A1 WO2014069649 A1 WO 2014069649A1 JP 2013079803 W JP2013079803 W JP 2013079803W WO 2014069649 A1 WO2014069649 A1 WO 2014069649A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- formula
- salt
- chemical formula
- defined above
- Prior art date
Links
- 0 *C(C(N(C(C1Nc2ccccc2)[S+]C23CC2)C1=O)=C3I*)=O Chemical compound *C(C(N(C(C1Nc2ccccc2)[S+]C23CC2)C1=O)=C3I*)=O 0.000 description 8
- IXJRDVSAEOKBGL-UHFFFAOYSA-N Cc1ccc(C(NC)O)c(O)c1 Chemical compound Cc1ccc(C(NC)O)c(O)c1 IXJRDVSAEOKBGL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Definitions
- the invention relates to processes of intermediates for preparing 2-alkyl cephem compounds useful as antimicrobial drugs .
- Patent Document 1 EP 0035357 Al
- Non-Patent document 1 Chemical & Pharmaceutical Bulletin, vol.31, 1482-1493 (1983)
- the subject invention provides processes for the production of intermediates for the synthesis of 2-alkyl cephems compounds, in particularly, a process for selectively producing 2-methyl cephems compounds in high yield.
- the subject invention provides the following inventions:
- R 5A is lower alkyl
- Y is a leaving group
- L is a single bond, lower alkylene or lower alkenylene;
- P 1 is acyl or an amino-protecting group;
- P 2 is a carboxy-protecting group; which comprises:
- R 5A is lower alkyl
- Y is a leaving group
- L is a single bond, lower alkylene or lower alkenylene
- P 1 is acyl or an amino-protecting group
- P 2 is a carboxy-protecting group; which comprises:
- the wavy line means that the bond is a mixture of -configuration and ⁇ -configuration
- R 5A is lower alkyl
- Y is a leaving group
- L is a single bond, lower alkylene or lower alkenylene;
- P 1 is acyl or an amino-protecting group;
- P 2 is a carboxy-protecting group; which comprises:
- R 5 is hydrogen or lower alkyl
- R 5A is lower alkyl
- Y is a leaving group
- L is a single bond, lower alkylene or lower alkenylene;
- P 1 is acyl or an amino-protecting group;
- P 2 is a carboxy-protecting group; which comprises:
- R is lower alkyl
- Y is a leaving group
- P 1 is acyl or an amino-protecting group
- P 2 is a carboxy-protecting group
- each symbol is as defined above; with an acid to give a compound of the formula (I-l) or a salt thereof .
- the wavy line means that the bond is a mixture of a-configuration and ⁇ -configuration
- L is a single bond and Y is halogen; and 2) L is lower alkylene or lower alkenylene and Y is acetyl
- L is lower alkylene or lower alkenylene and Y is acetyl.
- L is lower alkylene or lower alkenylene and Y is acetyl.
- L is lower alkylene or lower alkenylene and Y is acetyl.
- L is lower alkylene or lower alkenylene
- Y is halogen
- R 5 is hydrogen
- the wavy line means that the bond is in cis or trans configuration, or a mixture thereof;
- a compound according to any one of the above 17 to 20 wherein Y is methanesulfonyloxy, trifluoromethanesulfonyloxy or p-toluenesulfonyloxy; L is a single bond; and R 5A is methyl.
- a method for transforming 2-a-alkyl-cephem compound to 2- -alkyl-cephem compound which comprises reaction of the 2- -methyl-cephem compound with a base.
- the processes and intermediates of the subject invention are useful as an industrial production of 2-alkyl cephem compounds.
- a variety of 2-alkyl cephem compounds or their derivatives can be synthesized efficiently and conveniently, e.g., in short steps, in high yield, in high purity, in high selectivity, and/or under mild conditions.
- Fig. 1 shows a powder X-ray diffraction pattern of the crystal of compound XVI-2 obtained in (2) . of Example 7.
- the vertical axis is intensity (cps)
- the horizontal axis is 2-theta angles (degree) .
- the peak at about 38 degree is Al peak as the sample holder.
- Fig. 2 shows a powder X-ray diffraction pattern of the crystal of compound II-3 obtained in (4) of Example 7.
- the vertical axis is intensity (cps), and the horizontal axis is 2-theta angles (degree) .
- the peak at about 38 degree is Al peak as the sample holder.
- Fig. 3 shows a powder X-ray diffraction pattern of the crystal of compound III-2 obtained in (7) of Example 7.
- the vertical axis is intensity (cps)
- the horizontal axis is 2-theta angles (degree) .
- the peak at about 38 degree is Al peak as the sample holder.
- Halogen includes fluorine, chlorine, bromine and iodine .
- halogen is fluorine, chlorine or bromine, and more preferably is chlorine.
- “Lower alkyl” includes linear or branched alkyl having 1-8 carbons, preferably 1-6 carbons, and more preferably 1-4 carbons, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, hexyl, isohexyl, n-heptyl, xsoheptyl, n-octyl, and the like.
- Preferred is methyl.
- “Lower alkylene” includes linear alkylene having 1-8 carbons, preferably 1-6 carbons, more preferably 1-4 carbons, and most preferably one or two carbons, for example, methylene, ethylene, n-propylene, n-butylene, n-pentylene, n-hexylene, and the like.
- “Lower alkenylene” includes linear alkenylene having 2-8 carbons, preferably 2-6 carbons, more preferably 2-4 carbons, and at least one double bond at any position, and includes, for example, vinylene, allylene, propenylene, butenylene, prenylene, butadienylene, pentenylene, pentadienylene, hexenylene, hexadienylene, and the like.
- “Lower alkynylene” includes linear alkynylene having 2-8 carbons, preferably 2-6 carbons, more preferably 2-4 carbons, and at least one triple bond at any position, for example, ethynylene, propynylene, buthynylene, pentynylene, hexynylene, and the like.
- “Lower alkoxy” includes linear or branched alkoxy having
- 1-8 carbons preferably 1-6 carbons, and more preferably 1-4 carbons, for example, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, n-pentoxy, isopentxy, neopentoxy, hexyoxy, isoheptyloxy, isoheptyloxy, n-octyloxy, n-octyloxy, and the like.
- Alkyl includes alkyl having one to three groups selected from above “aryl”, preferably wherein cabon number of alkyl part is 1 or 4, more preferably is 1 or 2, for example, benzyl, phenethyl, phenylpropyl, trityl, and the like.
- Heteroaralkyl includes alkyl having one to three groups selected from above “heteroaryl", preferably wherein cabon number of alkyl part is 1 or 4, more preferably is 1 or 2, for example, furylmethyl, thienylmethyl, pyrolylmethyl, pyridylmethyl, thienylethyl , furylethyl, imidazorylmethyl , benzotienylmethyl, thiazolylmethyl, and the like.
- “Lower alkyl” of "tri-lower alkylsilyl” is as defined above, for example, trimethylsilyl , t-butyldimethylsilyl and the like.
- Acyl includes formyl, optionally substituted lower alkylcarbonyl (e.g., acetyl, propionyl, butylyl, isobutylyl, valeryl, isovaleryl, pivaloyl, hexanoyl, octanoyl, methoxyethylcarbonyl , 2, 2, 2-trifluoroethylcarbonyl) , optionally substituted alkenyloxycarbonyl (e.g., alloc, cinnamyloxy carbonyl) , alkoxycarbonylacetyl (e.g., ethoxycarbonylmethylcarbonyl ) ,
- lower alkylcarbonyl e.g., acetyl, propionyl, butylyl, isobutylyl, valeryl, isovaleryl, pivaloyl, hexanoyl, octanoyl, methoxyethylcarbony
- ( lower) alkylcarbamoyl ( lower ) alkylcarbonyl (e.g., methylcarbamoylethylcarbonyl ) , optionally substituted arylcarbonyl (e.g., benzoyl, toluoyl) , optionally substituted cycloalkyloxy carbonyl (e.g., cycrohexyloxycarbonyl ) , optionally substituted aralkyloxy carbonyl (e.g., benzyloxycarbonyl , p-nitrobenzyloxycarbonyl ) , optionally substituted heteroaralkyl carbonyl (e.g., thienylmethyl carbonyl ) and the like.
- Acyl includes a group of formula (Pl-1) mentioned hereafter.
- Aryl includes phenyl, naphthyl, anthryl, phenanthryl, and the like, and phenyl is preferable.
- Heterocyclic group includes heterocyclic groups having at least one hetero atom arbitrarily selected from 0, S, and N in the ring, and includes, for example, 5- or 6-membered heteroaryl such as pyrrolyl, imidazolyl, pyrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazolyl, triazinyl, tetrazolyl, isoxazolyl, oxazolyl, oxadiazolyl, isothiazolyl, thiazolyl, thiadiazolyl, furyl, thienyl, and the like; bicyclic fused heterocyclic groups such as indolyl, isoindolyl, indazolyl, indolizinyl, indolinyl, isoindolinyl , quinolyl, isoquinolyl, cinnolinyl, phthalazinyl, quin
- the carboxy protecting groups is explained, for example, in Protective Groups in Organic Synthesis, written by T. W. Greene, John Wiley & Sons Inc. (1991), or the like.
- Examples thereof include lower alkyl (e.g., methyl, ethyl, t-butyl), (lower) alkylcarbonyloxymethyl (e.g., pivaloyl) , optionally substituted aralkyl (e.g., benzyl, benzhydryl, phenethyl, p-methoxybenzyl, p-nitrobenzyl ) , silyl groups
- the amino-protecting group is explained, for example, in Protective Groups in Organic Synthesis , written by T. W. Greene, John Wiley & Sons Inc. (1991), or the like.
- Examples thereof include phthalimide, acyl (formyl, optionalluy substituted alkylcarbonyl (chloroacetyl, trichloroacetyl etc.), lower alkoxycarbonyl (butoxycarbonyl (Boc) , benzyloxy carbonyl etc.), lower alkenyloxycarbonyl (allyloxycarbonyl (Alloc), etc.), optionally subasittuted aralkyloxycarbonyl (benzyloxycarbonyl ,
- the hydroxy-protecting group is explained, for example, in Protective Groups in Organic Synthesis, written by T. W. Greene, John Wiley & Sons Inc. (1991), or the like.
- Examples thereof include lower alkoxycarbonyl such as a C1-C4 alkoxycarbonyl (e.g., t-butyloxycarbonyl), halogenated lower alkoxycarbonyl such as a halogenated (C1-C3) alkoxycarbonyl (e.g., 2-iodo ethyloxycarbonyl, 2, 2, 2-trichloroethyloxycarbonyl) , aryl- (lower) alkoxycarbonyl such as a phenyl- (C1-C4 ) alkoxycarbonyl having optionally a substituent ( s ) on the benzene ring (benzyloxycarbonyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, p
- Salts include, for example, salts formed with alkali metal (e.g. lithium, sodium, potassium, etc.), alkaline earth metal (e.g. calcium, barium, etc . ) , magnesium, transition metal (e.g. zinc, ferrum, etc.), ammonia, organic base (e.g. trimethylamine, triethylamine, dicyclohexylamine, ethanolamine, diethanolamine, triethanolamine, meglumine, diethanolamine, ethylenediamine, pyrydine, picoline, quinoline, etc.) and amino acid, or salts formed with inorganic acid (e.g.
- alkali metal e.g. lithium, sodium, potassium, etc.
- alkaline earth metal e.g. calcium, barium, etc .
- magnesium e.g. zinc, ferrum, etc.
- ammonia e.g. trimethylamine, triethylamine, dicyclohexylamine, ethanolamine, diethanolamine, triethanol
- These salts can be formed according to the conventional method. These salts may be solvate such as hydrate and alcholate.
- the leaving group includes halogen (CI, Br, I, F) , acetoxy, substituted sulfonyloxy (e.g., methanesulfonyloxy, optionally substituted benzensulfonyloxy (e.g., benzenesulfonyloxy, p-toluenesulfonyloxy) trifluoromethanesulfonyloxy) , and the like.
- Preffered is halogen (CI, Br, I), acetoxy, methanesulfonyloxy p-toluenesulfonyloxy or trifluoromethanesulfonyloxy . More preffered is halogen (CI, Br, I), acetoxy, methanesulfonyloxy, p-toluenesulfonyloxy .
- the intermediates of the present invention may be reacted with a variety of materials for forming each side chain moiety at the 3-, 4 ⁇ and/or 7-position of the cephem skeleton, if necessary in combination with the deprotection of an amino-protecting group and/or a carboxy-protecting group, to obtain various 2-alkyl cephem compounds.
- R 1 is an optionally substituted carbocyclic group, an optionally substituted aryloxy, an optionally substituted heterocyclic group or an optionally substituted heteroaryloxy; with regard to R 2A and R 2B , a) R A is hydrogen, optionally substituted amino, -S0 3 H, optionally substituted amino sulfonyl, carboxyl, optionally substituted (lower alkyl ) oxycarbonyl , optionally substituted carbamoyl, hydroxyl, or substituted carbonyloxy; and R 2B is hydrogen, provided that R 2A and R 2B are not hydrogen at the same time, or
- R A and R 2B are taken together to form optionally substituted methylidene or optionally substituted hydroxyimino .
- Examples of “optionally substituted carbocyclic group”, “optionally substituted aryloxy”, “optionally substituted heteroaryloxy” or “optionally substituted heterocyclic group” of R 1 include phenyl, aminothiazole, aminothiadiazole, thiophene, furan, benzothiazole, pyridine, pyrimidine, pyridazine, aminopyridine, phenoxy, pyridiloxy, and the like, each optionally substituted with hydroxyl and/or halogen.
- Preferred Examples include the followings:
- R 2A examples include hydrogen, optionally substituted amino, -C00H, -S0 3 H, optionally substituted aminosulfonyl, carboxyl, optionally substituted carbamoyl, hydroxyl, substituted carbonyloxy, and the like.
- R 2B is hydrogen and R 2a is the folloing group:
- ring B represents an optionally substituted heterocyclic group
- ring B represents an optionally substituted heterocyclic group; or 4) substituted carbonyloxy shown below:
- ring B represents an optionally substituted.
- R 2A and R B may be taken together to form a substituted methylidene group shown below:
- R 9 is optionally substituted lower alkyl. Preferred is the group shown below:
- R 2A and R 2B may be taken together to form optionally substituted hydroxyimino shown below:
- R 9 is as defined above. Preferred is a group shown below .
- R and R are each independently a hydrogen atom, halogen, hydroxyl group, carboxyl group, an optionally substituted lower alkyl group, an optionally substituted carbocyclic group, or an optionally substituted heterocyclic group, or
- R 7 and R 8 may be taken together with a neighboring atom to form an optionally substituted carbocyclic group or an optionally substituted heterocyclic group;
- Q is a single bond, an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; and m is an integer from 0 to 3.
- R 7 and R 8 includes hydrogen, fluoro , chloro, hydroxy, carboxy, methyl, ethyl, isopropyl, tert-butyl, monofluoromethyl, difluoromethyl, trifluoromethyl , carboxymethyl, carboxyethyl, carbamoylmethyl, carbamoylethyl, hydroxymethyl , hydroxyethyl, methoxymethyl, ethoxymethyl , methoxyethyl, ethoxyethyl, methylthiomethyl, ethylthiomethyl, benzyl, 4-hydroxybenzyl, 4-methoxybenzyl, 4-carboxybenzyl, 3 , 4-dihydroxybenzyl , phenyl, 4-hydroxyphenyl,
- Preferred combinations of ( 7 , R 8 ) include (hydrogen, hydrogen), (methyl, hydrogen), (hydrogen, methyl), (methyl, methyl), (ethyl, hydrogen), (hydrogen, ethyl), (ethyl, ethyl), (phenyl, hydrogen) , (hydrogen, phenyl) , (dihydroxyphenyl, hydrogen), (hydrogen, dihydroxyphenyl), (carboxymethyl, hydrogen) , (hydrogen , carboxymethyl) , (carboxyethyl, hydrogen) , (hydrogen, carboxyethyl) , (hydroxyethyl, hydrogen) , (hydrogen, hydroxylethyl ) , (carbamoylmethyl, hydrogen) , (hydrogen, carbamoylmethyl), (trifluoromethyl , hydrogen), (carboxy, hydrogen) , (carbamoylethyl, hydrogen) , (benzyl, hydrogen), (dihydroxybenzyl, hydrogen),
- Preferred examples of the above substituted hydroxyimino include groups shown bellow.
- R 7 and R 8 may be taken together with a neighboring atom to form an optionally substituted carbocyclic group or an optionally substituted heterocyclic group" in the formula:
- R 7 and R s may form cycloalkane, cycloalkene, or a non-aromatic heterocycle optionally substituted with a group selected from Substituent Group alpha.
- each ring is optionally substituted with a group selected from Substituent Group alpha.
- Q examples include a single bond, phenyl, pyridyl, and the like. A single bond is particularly preferable.
- m is preferably 0 or 1, and 0 is particularly preferable.
- P 1 More preffered examples of P 1 include a group represented by the formula:
- each symbol is as defined avobe .
- the crystal of compound XVI-2, compound II-3, and compound III-2 may be identified by their main or characteristic peaks obtained by powder X-ray diffraction analysis. These crystals may be solvates such as hydrates or alcholates. By isolating and using these crystals, the synthesis of 2-alkyl cephem can be conducted more efficiently.
- measurement error may occur in peaks to some extent depending on a measurement apparatus or measurement conditions. Specifically, for example a measurement error of about ⁇ 0.2 may occur in value of 2 ⁇ . Even when a very high-precision equipment is used a measurement error of about ⁇ 0.1 may occur. Therefore, measurement error should be considered in identifying each crystal structure.
- the crystals of the present invention have good stability, good handling, and/or high purity.
- P 1 is an amino-protecting group
- P 2 is a carboxy-protecting group
- P 3 is a hydroxyl-protecting group
- Y is a leaving group (e.g., a halogen (CI, Br, I, F) , acetoxy, substituted sulfonyloxy ( e.g. methanesulfonyloxy, optionally substituted benzensulfonyloxy (benzenesulfonyloxy, p-toluenesulfonyloxy, etc. ) trifluoromethanesulfonyloxy) , and the like.
- R 5 is hydrogen or lower alkyl; the other symbols are as defined above.
- the 4-carboxyl group of the compound (VIII) is protected with a carboxyl-protecting group by a conventional method to give the compound (IX).
- the carboxyl-protecting group is exemplified by diphenyl methyl, p-methoxybenzyl etc.
- the reaction solvents include, for example, ethers (e.g., dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether), esters (e.g., ethyl formate, ethyl acetate, isopropyl acetate), halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitriles (e.g., MeCN, propionitrile) , dimethylsulfoxide, water and
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -80°C to 80°C, more preferably from about -60°C to 60°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- amino-protecting group examples include phthalimide, acyl (formyl, optionalluy substituted alkylcarbonyl (chloroacetyl, trichloroacetyl etc.), lower alkoxycarbonyl (butoxycarbonyl (Boc) , benzyloxy carbonyl etc.), lower alkenyloxycarbonyl (allyloxycarbonyl (Alloc), etc.), optionally substituted aralkyloxycarbonyl (benzyloxycarbonyl,
- p-nitrobenzyloxycarbonyl etc. optionally substituted heteroaralkyicarbonyl ( thienylmethylcarbonyl etc.)), optionally substituted aralkanoyl (p-nitrobenzoyl , etc.), optionally substituted aralkyl (trityl, benzhydryl (BH) etc.), optionally substituted arylimino (N-benzylidene, N-salicylidene, N-2-methoxybenzylidene etc.), optionally substituted lower alkylimino (N-isopropylidene etc.) tri-lower alkylsilyl (trimethylsilyl, tert-butyldimethylsilyl etc.) and the like.
- the amino-ptotecting group is optionally substituted heteroaralkylcarbonyl (thienylmethylcarbonyl etc.), lower alkoxycarbonyl (butoxycarbonyl (Boc) , benzyloxy carbonyl etc.), optionally substituted aralkyl (trityl, benzhydryl (BH) etc.), formyl, chloroacetyl, trichloroacetyl or tri-lower alkylsilyl (trimethylsilyl, tert-butyldimethylsilyl etc.), more preferably is optionally substituted heteroaralkylcarbonyl (thienylmethylcarbonyl etc.).
- hydroxy-protecting group examples include lower alkoxycarbonyl such as a C1-C4 alkoxycarbonyl (e.g., t-butyloxycarbonyl ) , halogenated lower alkoxycarbonyl such as a halogenated (C1-C3) alkoxycarbonyl (e.g., 2-iodo ethyloxycarbonyl, 2 , 2, 2-trichloroethyloxycarbonyl ) , aryl- (lower) alkoxycarbonyl such as a phenyl- (C1-C ) alkoxycarbonyl having optionally a substituent ( s ) on the benzene ring (benzyloxycarbonyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl , p-methoxybenzyloxycarbonyl ) , p-methoxybenzyl (PMB), tri-lower alkylsilyl
- the compound (X) is obtained by subjecting the compound (IX) to oxidation reaction using an oxidant well-known to those skilled in the art (e.g., m-chloroperbenzoic acid, peracetic acid, performic acid, hydrogen peroxide) .
- an oxidant well-known to those skilled in the art (e.g., m-chloroperbenzoic acid, peracetic acid, performic acid, hydrogen peroxide) .
- the reaction solvents include, for example, ethers (e.g., anisole, dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether), esters (e.g., ethyl formate, ethyl acetate, n-butyl acetate, isopropyl acetate) , halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N, -dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitriles (e.g., MeCN, pro
- halogenated hydrocarbons e.g. dichloromethane, chloroform, carbon tetrachloride
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -80°C to 50°C, more preferably about -50°C to 0°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is carried out for 0.5 to 24 hours.
- the compound (X) is reacted with aldehyde (i.e., R 5 CHO) and a primary or secondary amine to give the compound (XI) .
- the aldehyde includes, for example, formaldehyde and lower alkyl aldehyde (e.g. acetaldehyde, propionaldehyde) .
- the aldehyde is generally used in an amount of about 1 to 100 mole, preferably 1 to 30 mole, for 1 mole of the compound (X) .
- the primary or secondary amine includes, for example, methylamine, dimethylamine, ethylamine and diethylamine .
- the primary or secondary amine, including its salt, is generally used in an amount of about 1 to 100 mole, preferably 1 to 30 mole, for 1 mole of the compound (X) .
- the reaction solvents include, for example, ethers (e.g., dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether), esters (e.g., ethyl formate, ethyl acetate, isopropyl acetate), halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N, -dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitriles (e.g., MeCN, propionitrile) , dimethylsulfoxide, water,
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -80°C to 80°C, more preferably from about 0°C to 80°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- the compound (XI) is reacted with a reductant (e.g., zinc, copper, mixture thereof) and an acid (e.g., Hydrochloric acid, acetic acid, formic acid) to give the compound (VI).
- a reductant e.g., zinc, copper, mixture thereof
- an acid e.g., Hydrochloric acid, acetic acid, formic acid
- Zinc is preferavly used in an amount of about 1 to 100 mole, preferably 1 to 30 mole, for 1 mole of the compound (XI) .
- the acid e.g., Hydrochloric acid, acetic acid, formic acid
- the reaction solvents include, for example, ethers (e.g., dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether), esters (e.g., ethyl formate, ethyl acetate, isopropyl acetate) , halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, -dimethylformamide, N, -dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitriles (e.g., MeCN, propionitrile) , acid (e.g.,
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -80°C to 80°C, more preferably from about -20°C to 60°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- the compound (VI) is reacted with an acid (e.g., hydrohalic acid, acetic acid, formic acid, methanesulfonic acid, torifluoromethanesulfonic acid, p-toluenesulfonic acid) to give the compound (1-1).
- an acid e.g., hydrohalic acid, acetic acid, formic acid, methanesulfonic acid, torifluoromethanesulfonic acid, p-toluenesulfonic acid
- the acid is hydrocholoric acid or hydrobromic acid.
- the acid is generally used in an amount of about 1 to 100 mole, preferably 1 to 30 mole, for 1 mole of the compound (VI) .
- the reaction solvents include, for example, ethers (e.g., anisole, dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether) , esters (e.g., ethyl formate, ethyl acetate, n-butyl acetate, isopropyl acetate) , halogenated hydrocarbons (e.g., dichloromethane , chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N, -dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitriles (e.g., Me
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -10°C to 50°C, more preferably from about -5°C to 30°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- the compound (I) is reacted with an oxidant well-known to those skilled in the art (e.g., m-chloroperbenzoic acid, peracetic acid, performic acid, hydrogen peroxide ) to give (IV), which is a stereoisomeric mixture of sulfoxide compounds.
- an oxidant well-known to those skilled in the art (e.g., m-chloroperbenzoic acid, peracetic acid, performic acid, hydrogen peroxide ) to give (IV), which is a stereoisomeric mixture of sulfoxide compounds.
- the oxidant is m-chloroperbenzoic acid.
- the reaction solvents include, for example, ethers (e.g., anisole, dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether) , esters (e.g., ethyl formate, ethyl acetate, n-butyl acetate, isopropyl acetate) , halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl e
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -80°C to 50°C, more preferably about -60°C to -20°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is carried out for 0.5 to 24 hours.
- the stereoisomeric mixture of the sulfoxide compounds of the formula (IV) is reacted with a base (e.g. triethylamine, trimethylamine, dicyclohexylamine, ethanolamine, diethanolamine, meglumine, diisopropylethylamine , ethylenediamine, pyridine, pycoline, quinoline) to give the single stereoisomer sulfoxide compound (II) as major product.
- a base e.g. triethylamine, trimethylamine, dicyclohexylamine, ethanolamine, diethanolamine, meglumine, diisopropylethylamine , ethylenediamine, pyridine, pycoline, quinoline
- the base is triethylamine or diisopropylethylamine.
- the reaction solvents include, for example, ethers (e.g., anisole, dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether) , esters (e.g., ethyl formate, ethyl acetate, n-butyl acetate, isopropyl acetate) , halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N, -dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitriles (e.g., MeCN
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -80°C to 50°C, more preferably about 0°C to 30°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is carried out for 0.5 to 24 hours.
- the obtained compound (II) can be purified by, for example, column chromatography, to give compound (II) in more high purity.
- the compound (I) is reacted with an oxydant to give the sulfoxide compound (V) as a maj or product .
- the compound (V) can, once isolated or not, be used in the next step 9.
- the oxidant is preferably peroxyacid (e.g., meta-chloro peroxybenzoic acid, peroxyacetic acid, performic acid, hydrogen peroxide, tert-buthyl hydroperoxide) , more preferably peroxiacid which can be washed out with water in the postreaction treatment (e.g. peroxyacetic acid, performic acid, hydrogen peroxide, tert-butyl hydroperoxide) .
- the oxidant is generally used in an amount of about 1 to 100 mole, preferably 1 to 30 mole, for 1 mole of Compound (I) .
- the reaction solvents include, for example, alcohols (e.g., methanol, ethanol) , halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N , N-dimethylacetamide, N-methylpyrrolidone) .
- halogenated hydrocarbons e.g. dichloromethane, chloroform, carbon tetrachloride
- solvent e.g., halogenated hydrocarbons (e.g. dichloromethane, chloroform, carbon tetrachloride) is used as solvent.
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -20°C to 20°C, more preferably from about -10°C to 10°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- the quench and postreaction treatment may be carried our by a conventional method of the oxidation reaction, where the solvent for washing is preferably water or brine.
- the compound (V) obtained by Step 8 is reacted with a base (e.g. triethylamine, sodium acetate, trimethylamine, diisopropylethylamine, dicyclohexylamine, ethanol amine, ehylenediamine, pyridine, picoline, quinoline, sodium carbonate, sodium hydrogen carbonate) to give the single stereoisomer sulfoxide compound (II) .
- a base e.g. triethylamine, sodium acetate, trimethylamine, diisopropylethylamine, dicyclohexylamine, ethanol amine, ehylenediamine, pyridine, picoline, quinoline, sodium carbonate, sodium hydrogen carbonate
- the base is sodium acetate, sodium hydrogen carbonate or sodium carbonate, more preferably the base is sodium acetate.
- the reaction solvents include, for example, water, alcohols (e.g., methanol, ethanol), halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone) , nitriles (e.g., acetonitrile, propionitrile) or a mixture thereof.
- the reaction solvent is a mixture of acetonitrile and water.
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -50°C to 50°C, more preferably from about 0°C to 40°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours. Prefarably, the reaction is performed at 20°C to 40°C for 0.5 to 4 hour, then cooled to ' 0°C to 10°C for 18 to 24 hours.
- the reaction pH is preferably from 5 to 8.
- Step 10 The compound (II) is reacted with a reductant (e.g., phosphorus trichloride, phosphorus tribromide) to give the compound ( III ) .
- a reductant e.g., phosphorus trichloride, phosphorus tribromide
- the reductant e.g., phosphorus trichloride, phosphorus tribromide
- the reductant is generally used in an amount of about 1 to 100 mole, preferably 1 to 30 mole, for 1 mole of Compound (II) .
- the reaction solvents include, for example, halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N, -dimethylacetamide, N-methylpyrrolidone) .
- halogenated hydrocarbons e.g., dichloromethane, chloroform, carbon tetarachloride
- hydrocarbons e.g., n-hexane, benzene, toluene
- amides e.g., formamide, N, N-dimethylformamide, N, -dimethylacetamide, N-methylpyrrolidone
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -80°C to 50°C, more preferably from about -60°C to 0°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- the reaction solvents include, for example, ethers (e.g., anisole, dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether) , esters (e.g., ethyl formate, ethyl acetate, n-butyl acetate, isopropyl acetate) , halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, -dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitriles (e.g., MeCN
- the reaction temperature is usually in the range of from about -100°C to 100°C, preferably from about -50°C to 50°C, more preferably from about -40°C to 30°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- P 1 is acyl or an amino-protecting group
- P 2 is a carboxy-protecting group
- L is a single bond, lower alkylene or lower alkenylene
- Y is a leaving group (e.g., halogen (CI, Br, I, F) , acetoxy, substituted sulfonyloxy (e.g., methanesulfonyloxy, optionally substituted benzensulfonyloxy (e.g.
- R 5 is hydrogen or lower alkyl; the other symbols are as defined above.
- the 7-amino group of the compound (XX) or a salt thereof is acylated with an acylating reagent or protected with an amino-protecting group by a conventional method to give the compound (XVII) .
- the amino-protecting group is exemplified by benzoyl, phenoxy methyl carbonyl, thienyl methyl carbonyl etc.
- the reaction solvents include, for example, ethers (e.g., dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether), esters (e.g., ethyl formate, ethyl acetate, isopropyl acetate), halogenated hydrocarbons (e.g., dichloromethane , chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, -dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitriles (e.g., MeCN, propionitrile) , dimethylsulfoxide, water
- the reaction temperature is usually in the range of about -100°C to 100°C, preferably about -80°C to 80°C, more preferably about -60°C to 60°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- amino-protecting group examples include phthalimide, acyl (e.g., formyl, optionalluy substituted alkylcarbonyl (e.g., chloroacetyl , trichloroacetyl) , lower alkoxycarbonyl (e.g., butoxycarbonyl (:Boc), benzyloxy carbonyl) , lower alkenyloxycarbonyl (e.g., allyloxycarbonyl (:Alloc)), optionally subsittuted aralkyloxycarbonyl (e . g .
- benzyloxycarbonyl p-nitrobenzyloxycarbonyl
- optionally substituted heteroaralkylcarbonyl e.g., thienylmethylcarbonyl )
- optionally substituted aralkanoyl e.g., p-nitrobenzoyl ,
- optionally substituted aralkyl e.g., trityl, benzhydryl (:BH)
- arylimino e.g., N-benzylidene, N-salicylidene, N-2-methoxybenzylidene etc.
- optionally substituted lower alkylimino e.g., N-isopropylidene
- tri-lower alkylsilyl e.g., trimethylsilyl , tert-butyldimethylsilyl
- the araino-ptotecting group is optionally substituted heteroaralkylcarbonyl (e.g., thienylmethylcarbonyl ) , lower alkoxycarbonyl (e.g., butoxycarbonyl (:Boc), benzyloxy carbonyl) , optionally substituted aralkyl (e.g., trityl, benzhydryl (:BH)), formyl, chloroacetyl, trichloroacetyl or tri-lower alkylsilyl (e.g., trimethylsilyl, tert-butyldimethylsilyl) , more preferably is optionally substituted heteroaralkylcarbonyl (e.g., thienylmethylcarbonyl ) .
- heteroaralkylcarbonyl e.g., thienylmethylcarbonyl
- lower alkoxycarbonyl e.g., butoxycarbonyl (:Boc),
- carboxy protecting groups examples include lower alkyl (e.g., methyl, ethyl, t-butyl) , (lower) alkylcarbonyloxymethyl (e.g., pivaloyl) , optionally substituted aralkyl (e.g., benzyl, benzhydryl, phenethyl, p-methoxybenzyl, p-nitrobenzyl) , silyl groups (t-butyldimethylsilyl, diphenyl (t-butyl) silyl) , and the like.
- lower alkyl e.g., methyl, ethyl, t-butyl
- lower alkylcarbonyloxymethyl e.g., pivaloyl
- aralkyl e.g., benzyl, benzhydryl, phenethyl, p-methoxybenzyl, p-nitrobenzyl
- silyl groups
- the compound (XV) is obtained by subjecting the compound (XVII) to oxidation reaction using an oxidant well-known to those skilled in the art (e.g., m-chloroperbenzoic acid, peracetic acid, performic acid, hydrogen peroxide) .
- an oxidant well-known to those skilled in the art (e.g., m-chloroperbenzoic acid, peracetic acid, performic acid, hydrogen peroxide) .
- the reaction solvents include, for example, ethers (e.g., anisole, dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether), esters (e.g., ethyl formate, ethyl acetate, n-butyl acetate, isopropyl acetate), halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitriles (e.g., MeCN, propionit
- the reaction temperature is usually in the range of about -100°C to 100°C, preferably about -80°C to 50°C, more preferably about -50°C to Q°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, and is usually 0.5 to 24 hours.
- the compound (XVI) is obtained by reacting aldehyde, amine, and the compound (XV) .
- the reaction is preferably conducted in the presence of an acid.
- the aldehyde includes aldehyde equivalent such as self-polymer (e.g., paraformaldehyde, paraldehyde, trioxane) , hydrate, hemiacetal, acetal and the like.
- self-polymer e.g., paraformaldehyde, paraldehyde, trioxane
- the amine include primary amine, secondary amine , tertiary amine, amino acid and a salt thereof (e.g., hydrochloride salt, sulfate salt), preffered is secondary amine (e.g., dimethylamine, diisopropylamine, N-methyl-p-anisidine, morpholine, pyrrolidine) or amino acid (e.g., L-proline, D-proline, N-methylglycine) .
- a salt thereof e.g., hydrochloride salt, sulfate salt
- preffered is secondary amine (e.g., dimethylamine, diisopropylamine, N-methyl-p-anisidine, morpholine, pyrrolidine) or amino acid (e.g., L-proline, D-proline, N-methylglycine) .
- Imine which is obtained by reacting the aldehyde and the amine may be used as an alternative for the aldehyde and the amine.
- the acid includes acetic acid, trifuluoiroacetic acid formic acid, methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid.
- the acid is generally used in an amount of about 0.5 to 100 mole, preferably 1 to 20 mole for 1 mole of the compound (XV) .
- the reaction solvents include, for example, ethers (e.g., anisole, dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether) , esters (e.g., ethyl formate, ethyl acetate, n-butyl acetate, isopropyl acetate) , halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dirnethylformamide, N, -dimethy1acetamide, N-methylpyrrolidone) , nitriles (e.g., MeCN, propionitrile) , nitros (e.g., nitro
- halogenated hydrocarbons e.g. dichloromethane , chloroform, carbon tetrachloride
- amides e.g., formamide, N, -dimethylformamide, N, N-dimethylacetamide,
- N-methylpyrrolidone or ethers (e.g., anisole, dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether) are used.
- ethers e.g., anisole, dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether
- the reaction temperature is usually in the range from about -100 e C to 100°C, preferably from about -80°C to 80°C, more preferably about -20°C to 70°C.
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- the compound (XVI) is reacted with a reductant (e.g. borane-ether complex, sodium borohydrate, sodium triacetoxyborohydrate, lithium aluminium hydride, diisobuthylalminiumu hydride) to give the compound (II) .
- a reductant e.g. borane-ether complex, sodium borohydrate, sodium triacetoxyborohydrate, lithium aluminium hydride, diisobuthylalminiumu hydride
- the reductant is preferably used in an amount of about 0.1 to 10 mole, preferably 0.2 to 5 mole, for 1 mole of the compound (XVI) .
- the reaction solvents include, for example, alcohols (e.g., methanol, ethanol, isopropanol) , ethers (e.g., dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether) , esters (e.g., ethyl formate, ethyl acetate, isopropyl acetate), halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, -dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), nitrile
- the reaction temperature is usually in the range of about -100°C to 100 a C, preferably about -80°C to 50°C, more preferably about -80°C to 0°C.
- the compound (II) may be obtained by hydrogenation reaction of the compound (XVI) with a metallic catalyst under H 2 gas.
- the metallic catalyst includes rhodium metal, palladium on carbon, platinum oxide and the like.
- the reaction solvents include, for example, alcohols (e.g., methanol, ethanol, isopropanol) , ethers (e.g., dioxane, tetrahydrofuran, diethyl ether, tert-butyl methyl ether, diisopropyl ether ) , esters (e.g., ethyl formate, ethyl acetate, isopropyl acetate), halogenated hydrocarbons (e.g., dichloromethane, chloroform, carbon tetarachloride ) , hydrocarbons (e.g., n-hexane, benzene, toluene), amides (e.g., formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone) , ketones (e.g., acetone, methyl ethyl ketone), n
- the reaction time may vary according to the reagents, solvents or reaction temperature to be employed, but usually is 0.5 to 24 hours.
- the protecting group to be used in the above reactions such as amino-protecting groups, hydroxy-protecting groups, etc. includes, for example, protecting groups described in Protective Groups in Organic Synthesis, written by T . . Greene, John Wiley & Sons Inc. (1991), etc.
- Methods for the introduction and removal of a protecting group are methods commonly used in synthetic organic chemistry (see, for example, methods described in Protective Groups in Organic Synthesis, written by T. . Greene, John Wiley & Sons Inc. (1991)), etc.
- a functional group included in each substituent can be converted by a known method (e.g., those described in Comprehensive Organic Transformations, written by R. C. Larock (1989), etc.) in addition to the above production methods .
- Some of the compounds of the present invention can be used as a synthetic intermediate, leading to a new derivative.
- Intermediates and desired compounds produced in each of the above production methods can be isolated and purified by a purification method commonly used in the synthetic organic chemistry, for example, neutralization, filtration, extraction, washing, drying, concentration, recrystallization, any kind of chromatography, etc.
- a purification method commonly used in the synthetic organic chemistry for example, neutralization, filtration, extraction, washing, drying, concentration, recrystallization, any kind of chromatography, etc.
- intermediates can be subjected to a next reaction without any purification.
- the above-mentioned deprotecting reaction is carried out in a solvent such as tetrahydrofuran, dimethylformamide, diethyl ether, dichloromethane, toluene, benzene, xylene, cyclohexane, hexane, chloroform, ethyl acetate, butyl acetate, pentane, heptane, dioxane, acetone, acetonitrile, or a mixed solvent thereof, using a Lewis acid (e.g., A1C1 3 , SnCl 4 , TiCl 4 ) , a protonic acid (e.g., HC1, HBr, H 2 S0 , HCOOH) , and the like.
- a Lewis acid e.g., A1C1 3 , SnCl 4 , TiCl 4
- a protonic acid e.g., HC1, HBr, H 2 S0
- the obtained compound may further be chemically modified to give various cephem compunds, including 4-carboxylic acid, ester thereof, 7-acyl type compound, cephem compound having a quaternary ammonium group at the 3-methyl side chain, pharmaceutically acceptable salt, or a solvate thereof.
- NMR 2 H NMR
- Splitting patterns describe apparent mul iplicities and are designated as s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet) , m (muitiplet) , br (broad) .
- Mass spectra were run on Waters Open Architecture System, UPLC SQD MS analytical system.
- the compound was analyzed using a reverse phase column, e.g., Xbridge-C18, Sunfire-C18, Thermo Aquasil/Aquasil C18, Acquity HPLC C18, Acquity UPLC BEH C18, Shim-pack XR-ODS, Thermo Hypersil Gold eluted using an acetonitrile and water gradient with a iow percentage of an acid modifier such as 0.1% formic acid.
- a reverse phase column e.g., Xbridge-C18, Sunfire-C18, Thermo Aquasil/Aquasil C18, Acquity HPLC C18, Acquity UPLC BEH C18, Shim-pack XR-ODS, Thermo Hypersil Gold eluted using an acetonitrile and water gradient with a iow percentage of an acid modifier such as 0.1% formic
- Analytical HPLC was run using an Shimadzu system (10A-VP series or 20A series) with variable wavelength UV detection using COSMOSIL packed column (5C18-AR-II) and eluting with an acetonitrile/water gradient containing a 0.05% or 0.1% TFA modifier (added to each solvent) .
- TBS tert-butyldimethylsilyl
- V volume (ml) of solvent per weight (g) of starting material [0077]
- diffraction angle (2-theta angles).: 5.3°, 7.0°, 10.2°, 10.5°, 11.5°, 14.0°, 14.7°, 14.8°, 15.8°, 16.5°, 16.6°, 16.7°, 17.4°, 18.3°, 18.8°, 19.3°, 19.7°, 20.5°, 20.7% 21.1°, 21.3°, 21.6°, 23.0°, 23.2°, 23.5°, 23.8°, 24.2°, 24.6°, 25.5°, 26.6°, 26.9°, 27.2°, 27.5°, 27.9°, 28.4°, 29.6°, 29.9°, 30.9°, 31.3°, 31.5°, 33.8°, 34.4°, 35.0°.
- the organic layer was washed with 10% aqueous solution of sodium chloride (50 mL) , and then an organic layer was separated. The organic layer was dried over sodium sulfate and filtered. The filtrate was concentrated to give crude compound II-3.
- the crude compound II-3 was purified by column chromatography on silica gel, eluted with ethyl acetate and n-hexane and concentrated to afford a purified amorphous compound II-3 (4.41 g, 88.0%).
- X-ray diffraction angle (2-theta angles ) : 5.2°, 5.7°, 7.3°, 7.8°, 8.2°, 9.3°, 11.3°, 11.6°, 12.0°, 12.8°, 13.2°, 14.1°, 14.5°, 15.3°, 15.7°, 16.4°, 17.0°, 17.5°, 18.5°, 18.7°, 19.3°, 20.4°, 20.8°, 21.2°, 21.6°, 21.8°, 22.4°, 23.4°, 24.0°, 24.8°, 25.6°, 26.3°, 26.8°, 28.0°, 28.4°, 29.1°, 32.2°, 33.0°, 34.4°, 34.6°.
- the crude compound III-2 was purified by column chromatography on silica gel, eluted with ethyl acetate and n-hexane and concentrarted to afford a purified amorphous compound III-2 (2.76 g, 94%).
- X-ray diffraction angle (2-theta angles) : 4.8°, 6.2°, 7.7°, 8.1°, 8.8°, 9.1°, 9.6°, 10.0°, 10.6°, 11.4°, 12.3°, 14.4°, 14.9°, 15.7°, 16.4°, 16.9°, 17.3°, 17.8°, 18.4°, 19.3°, 19.6°, 20.2°, 21.4°, 21.8°, 22.1°, 24.4°, 25.0°, 25.3°, 25.9°, 28.8°, 34.4°.
- sodium borohydride 17.8 g, 0.472 mol, 0.6 eq
- N-methylpyrrolidone solution containing compound XVI-6 was added dropwise for 70 minutes at -50 to -40 °C. The resulting mixture was stirred at this temperature for 1 hour.
- trifluoroacetic acid 145 mL, 1.89 mol, 2.4 eq
- water (2.04 L) dropwise for 6 minutes The mixture was stirred at room temperature for 2 hours.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2888543A CA2888543A1 (en) | 2012-10-29 | 2013-10-29 | Processes for production of intermediates for 2-alkyl cephem compounds |
KR1020157013522A KR20150076223A (en) | 2012-10-29 | 2013-10-29 | Processes for production of intermediates for 2-alkyl cephem compounds |
JP2015521169A JP2015535210A (en) | 2012-10-29 | 2013-10-29 | Process for the preparation of intermediates for 2-alkylcephem compounds |
CN201380066959.9A CN104854113A (en) | 2012-10-29 | 2013-10-29 | Processes for production of intermediates for 2-alkyl cephem compounds |
RU2015120084A RU2015120084A (en) | 2012-10-29 | 2013-10-29 | METHODS FOR PRODUCING INTERMEDIATE COMPOUNDS FOR 2-ALKYL CEPHEMIC COMPOUNDS |
BR112015008905A BR112015008905A2 (en) | 2012-10-29 | 2013-10-29 | processes for the production of intermediates of 2-alkyl cefem compounds |
US14/439,113 US9527866B2 (en) | 2012-10-29 | 2013-10-29 | Processes for production of intermediates for 2-alkyl cephem compounds |
EP13851709.9A EP2912040A4 (en) | 2012-10-29 | 2013-10-29 | Processes for production of intermediates for 2-alkyl cephem compounds |
AU2013339040A AU2013339040A1 (en) | 2012-10-29 | 2013-10-29 | Processes for production of intermediates for 2-alkyl cephem compounds |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261719523P | 2012-10-29 | 2012-10-29 | |
US61/719,523 | 2012-10-29 | ||
US201261720520P | 2012-10-31 | 2012-10-31 | |
US61/720,520 | 2012-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014069649A1 true WO2014069649A1 (en) | 2014-05-08 |
Family
ID=50627541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2013/079803 WO2014069649A1 (en) | 2012-10-29 | 2013-10-29 | Processes for production of intermediates for 2-alkyl cephem compounds |
Country Status (10)
Country | Link |
---|---|
US (1) | US9527866B2 (en) |
EP (1) | EP2912040A4 (en) |
JP (1) | JP2015535210A (en) |
KR (1) | KR20150076223A (en) |
CN (1) | CN104854113A (en) |
AU (1) | AU2013339040A1 (en) |
BR (1) | BR112015008905A2 (en) |
CA (1) | CA2888543A1 (en) |
RU (1) | RU2015120084A (en) |
WO (1) | WO2014069649A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2016035847A1 (en) * | 2014-09-04 | 2017-06-22 | 塩野義製薬株式会社 | Intermediate of cephalosporin derivative and method for producing the same |
US10174053B2 (en) | 2012-10-29 | 2019-01-08 | Glaxo Group Limited | 2 substituted cephem compounds |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107848968B (en) * | 2015-08-20 | 2021-06-18 | 荷兰联合利华有限公司 | Process for preparing lactams from glyoxylic acid |
CN110590811B (en) * | 2019-09-27 | 2022-05-03 | 广州白云山天心制药股份有限公司 | Preparation method of cefuroxime axetil-3-ene isomer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5259186A (en) * | 1975-11-11 | 1977-05-16 | Shionogi & Co Ltd | Preparation of 3-cephem compounds by reduction |
JPS56118085A (en) * | 1980-02-25 | 1981-09-16 | Takeda Chem Ind Ltd | 2-methylcephalosporin derivative and its preparation |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3487079A (en) | 1966-01-14 | 1969-12-30 | Bristol Myers Co | Certain alpha-amino bicyclic beta-lactam carboxylic acids |
US3660396A (en) * | 1970-03-04 | 1972-05-02 | Lilly Co Eli | Cephalosporin intermediates and process therefor |
JPH0228185A (en) | 1988-04-14 | 1990-01-30 | Tanabe Seiyaku Co Ltd | Cephalosporin compound and synthetic intermediate thereof |
PH25965A (en) | 1988-06-06 | 1992-01-13 | Fujisawa Pharmaceutical Co | New cephem compounds which have antimicrobial activities |
GB8813945D0 (en) | 1988-06-13 | 1988-07-20 | Fujisawa Pharmaceutical Co | New cephem compounds & process for preparation thereof |
GB8817653D0 (en) | 1988-07-25 | 1988-09-01 | Fujisawa Pharmaceutical Co | New cephem compounds & processes for preparation thereof |
US5143910A (en) | 1989-09-07 | 1992-09-01 | Shionogi & Co., Ltd. | Piperaziniocephalosporins |
GB9005246D0 (en) | 1990-03-08 | 1990-05-02 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
US5095012A (en) | 1990-08-23 | 1992-03-10 | Bristol-Myers Squibb Company | Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof |
GB9111406D0 (en) | 1991-05-28 | 1991-07-17 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
GB9118672D0 (en) | 1991-08-30 | 1991-10-16 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
TW200305422A (en) | 2002-03-18 | 2003-11-01 | Shionogi & Co | Broad spectrum cefem compounds |
CN100519563C (en) * | 2002-10-02 | 2009-07-29 | 日本曹达株式会社 | Processes for preparation of organic compounds |
WO2007096740A2 (en) | 2006-02-20 | 2007-08-30 | Orchid Research Laboratories Limited | Novel cephalosporins |
EP1994035A1 (en) | 2006-03-16 | 2008-11-26 | Astellas Pharma Inc. | Cephem compounds and use as antimicrobial agents |
ME02666B (en) | 2008-10-31 | 2017-06-20 | Shionogi & Co | Cephalosporin having catechol group |
WO2011125966A1 (en) | 2010-04-05 | 2011-10-13 | 塩野義製薬株式会社 | Cephem compound having pseudo-catechol group |
WO2011125967A1 (en) | 2010-04-05 | 2011-10-13 | 塩野義製薬株式会社 | Cephem compound having catechol group |
WO2011136268A1 (en) | 2010-04-28 | 2011-11-03 | 塩野義製薬株式会社 | Novel cephem derivative |
UY35103A (en) * | 2012-10-29 | 2014-05-30 | Glaxo Group Ltd | 2-REPLACED CEFEM COMPOUNDS |
-
2013
- 2013-10-29 RU RU2015120084A patent/RU2015120084A/en not_active Application Discontinuation
- 2013-10-29 JP JP2015521169A patent/JP2015535210A/en active Pending
- 2013-10-29 AU AU2013339040A patent/AU2013339040A1/en not_active Abandoned
- 2013-10-29 KR KR1020157013522A patent/KR20150076223A/en not_active Application Discontinuation
- 2013-10-29 BR BR112015008905A patent/BR112015008905A2/en not_active IP Right Cessation
- 2013-10-29 CA CA2888543A patent/CA2888543A1/en not_active Abandoned
- 2013-10-29 CN CN201380066959.9A patent/CN104854113A/en active Pending
- 2013-10-29 WO PCT/JP2013/079803 patent/WO2014069649A1/en active Application Filing
- 2013-10-29 EP EP13851709.9A patent/EP2912040A4/en not_active Withdrawn
- 2013-10-29 US US14/439,113 patent/US9527866B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5259186A (en) * | 1975-11-11 | 1977-05-16 | Shionogi & Co Ltd | Preparation of 3-cephem compounds by reduction |
JPS56118085A (en) * | 1980-02-25 | 1981-09-16 | Takeda Chem Ind Ltd | 2-methylcephalosporin derivative and its preparation |
Non-Patent Citations (5)
Title |
---|
GUNDA, T.E.: "An Improved Preparation of 2-Methylele- and 2,3-Dimethylenephalosporins", LIEBIGS ANNALEN DER CHEMIE, 1990, pages 311 - 312, XP055183535 * |
MIZOKAMI, N. ET AL.: "Synthesis of 2a-Methyl- and 2p-Methyl-3-(substituted methyl)cephalosporins, and 2,3-Diexomethylenecepham", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 31, no. 5, 1983, pages 1482 - 1493, XP055184198 * |
PITLIK, J ET AL.: "Cycloaddition Reactions of Cephalosporin Compounds.XI[1]", JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 26, no. 2, 1989, pages 461 - 464, XP055183540 * |
See also references of EP2912040A4 * |
SPRY, D.O.: "C(2)-VINYLHALO-CEPHEMS", TETRAHEDRON LETTERS, vol. 21, no. 14, 1980, pages 1289 - 1292, XP055183545 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10174053B2 (en) | 2012-10-29 | 2019-01-08 | Glaxo Group Limited | 2 substituted cephem compounds |
JPWO2016035847A1 (en) * | 2014-09-04 | 2017-06-22 | 塩野義製薬株式会社 | Intermediate of cephalosporin derivative and method for producing the same |
Also Published As
Publication number | Publication date |
---|---|
KR20150076223A (en) | 2015-07-06 |
CA2888543A1 (en) | 2014-05-08 |
RU2015120084A (en) | 2016-12-27 |
US20150291619A1 (en) | 2015-10-15 |
EP2912040A1 (en) | 2015-09-02 |
JP2015535210A (en) | 2015-12-10 |
EP2912040A4 (en) | 2016-06-01 |
CN104854113A (en) | 2015-08-19 |
US9527866B2 (en) | 2016-12-27 |
BR112015008905A2 (en) | 2017-07-04 |
AU2013339040A1 (en) | 2015-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2562080T3 (en) | Process and intermediate compounds to prepare integrase inhibitors | |
ES2513441T3 (en) | Procedure for the preparation of pharmaceutically active compounds | |
US20040167157A1 (en) | Process for preparation of amidine derivatives | |
CN113227061A (en) | Novel salts and polymorphs of bipedac acid | |
ES2575864T3 (en) | Processes and intermediates to prepare pralatrexate | |
KR20020082898A (en) | Novel process for producing fused imidazopyridine derivative and novel crystal form | |
RU2742005C2 (en) | Methods for producing 4-alkoxy-3-(acyl or alkyl)oxypicolinamides | |
WO2014069649A1 (en) | Processes for production of intermediates for 2-alkyl cephem compounds | |
JP2006501305A (en) | Cefdinir intermediate salt | |
CN116670142A (en) | MK2 inhibitors, their synthesis and intermediates | |
JP2006511561A (en) | Crystalline cefdinir salt | |
CN112218856A (en) | Process for preparing apaluramine | |
US20230278960A1 (en) | Novel acridinium salt and method for producing same | |
JP5816262B2 (en) | Method for producing dithiintetracarboximides | |
US20090137821A1 (en) | Method of making dorzolamide hydrochloride | |
US20090036672A1 (en) | Intermediate cefdinir salts | |
WO2013002215A1 (en) | Cephem compound having pyridinium group | |
KR100342600B1 (en) | New Thiazole compounds and their preparations | |
JP2016079098A (en) | Cephem compound | |
JPH0134227B2 (en) | ||
CN105073759A (en) | Cephem compound | |
CA2520083A1 (en) | Novel crystal of 7-[2-[(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof | |
JP5234856B2 (en) | Crystal of compound having NPYY5 receptor antagonistic action | |
JP2005255630A (en) | Ethyl trans-4-amino-1-cyclohexanecarboxylate salt and method for producing the same | |
JP2000169445A (en) | Production of optically active 4-mercapto-2-pyrrolidinone derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13851709 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2013851709 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013851709 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2888543 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2015521169 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14439113 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2013339040 Country of ref document: AU Date of ref document: 20131029 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015008905 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 20157013522 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2015120084 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 112015008905 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150420 |